Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene
about
LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectivesAge-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory systemEmotional manifestations of PD: Neurobiological basis.A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.The relevance of gender in Parkinson's disease: a review.Clinical Features of LRRK2 Carriers with Parkinson's Disease.Arm swing as a potential new prodromal marker of Parkinson's disease.Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.Cognitive changes in prodromal Parkinson's disease: A review.DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.Intact working memory in non-manifesting LRRK2 carriers--an fMRI study.Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.
P2860
Q28078899-3C81B6F2-8845-4626-A8F9-4F5907DB4817Q35850713-EC9C9FC8-A9DE-4659-8D36-7F7AA08F5BC2Q36470291-3B2F3DAC-B22E-4EFE-ADA3-A80E9C3AA464Q38752945-FD43D63B-4C44-4E3A-A7A3-79305B2C8ED5Q38797335-8A100F19-AD49-450D-9028-D4BC94D0E3D4Q38843010-3395A3AC-729D-4AE9-B2C2-688DD4DDB77FQ38859352-64C74F8A-44C7-4834-9B3E-CBDD8219C185Q39039214-6BF4B98F-93B7-4669-A72A-0067D77F6158Q39206423-7C9CF2F8-965F-40D1-9F7C-6FD6EA1DEAE6Q41355527-F19ECF20-405D-4A34-BC29-DA627E5165DDQ44060284-CFECD03C-6DC7-445C-B0C1-C8DE5443E4C8Q47701585-420B99FE-CE6E-4956-9008-251ECB155F01Q47860019-21AC8B34-AA27-49BC-A63F-04BFEE28257DQ47907932-D04D53EA-6495-4A7C-BB85-D8C8AD8A6B7CQ47972063-50889B85-8A67-4954-90ED-9F6BF2775816Q48192270-C2AC24E8-5374-4EE9-995D-322832D21575Q51758052-E54D0D1C-7BB6-4042-94D8-5F0524B34600
P2860
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nonmotor symptoms in healthy A ...... 19S mutation in the LRRK2 gene
@ast
Nonmotor symptoms in healthy A ...... 19S mutation in the LRRK2 gene
@en
type
label
Nonmotor symptoms in healthy A ...... 19S mutation in the LRRK2 gene
@ast
Nonmotor symptoms in healthy A ...... 19S mutation in the LRRK2 gene
@en
prefLabel
Nonmotor symptoms in healthy A ...... 19S mutation in the LRRK2 gene
@ast
Nonmotor symptoms in healthy A ...... 19S mutation in the LRRK2 gene
@en
P2093
P2860
P50
P356
P1433
P1476
Nonmotor symptoms in healthy A ...... 19S mutation in the LRRK2 gene
@en
P2093
Anat Bar-Shira
Anat Mirelman
Avner Thaler
Deborah Raymond
Helen Mejia-Santana
Karen Marder
Kira Yasinovsky
LRRK2 AJ consortium
Laurie Ozelius
Lorraine Clark
P2860
P304
P356
10.1002/MDS.26213
P407
P577
2015-03-21T00:00:00Z